Physician profile
Donna Cross
NPI 1760155675
$5,099.60
in general payments reported to CMS, 2019-2025
21 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.73 · 2022: $1,322 · 2023: $1,164 · 2024: $2,087 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Travel and Lodging: $888 · Education: $74.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.14 |
| Travel and Lodging | $888.23 |
| Education | $74.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,167.94 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Accurian |
| Forte Bio-Pharma LLC | $672.15 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Abbott Laboratories | $449.08 | 2022-2024 | Proclaim |
| Nevro Corp. | $242.59 | 2023-2024 | Senza |
| Collegium Pharmaceutical, INC. | $198.21 | 2022-2025 | Belbuca |
| Biohaven Pharmaceutical Holding Company LTD. | $183.77 | 2022 | |
| Nalu Medical, INC. | $174.79 | 2024 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $151.22 | 2023 | Intracept |
| Si-Bone, INC. | $151.14 | 2023-2025 | |
| Amgen INC. | $143.69 | 2022 | |
| Pfizer INC. | $124.40 | 2024-2025 | |
| Spr Therapeutics, INC | $108.57 | 2022-2025 | Sprint Pns System |
| Globus Medical, INC. | $93.02 | 2025 | Senza |
| Spinal Simplicity, LLC | $60.58 | 2023-2024 | Ha Minuteman G3-R |
| Abbvie INC. | $52.80 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $42.05 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.61 | 2024 | Relistor |
| Scilex Pharmaceuticals INC. | $18.57 | 2023 | Ztlido |
| Allergan, INC. | $17.77 | 2021 | |
| Stimwave Technologies Incorporated | $16.96 | 2021 | |
| Grt US Holding, INC. | $0.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.